Home - Products - MAPK/ERK Signaling - JNK - JNK-IN-13

JNK-IN-13

CAS No. 345986-38-1

JNK-IN-13( —— )

Catalog No. M37058 CAS No. 345986-38-1

JNK-IN-13 is a selective and potent JNK inhibitor that inhibits JNK3 and JNK2 and can be used in the study of diabetes, inflammation, and neurological disorders.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	31	In Stock
25MG	49	In Stock
50MG	79	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

JNK-IN-13
Note

Research use only, not for human use.
Brief Description

JNK-IN-13 is a selective and potent JNK inhibitor that inhibits JNK3 and JNK2 and can be used in the study of diabetes, inflammation, and neurological disorders.
Description

JNK-IN-13 (compound 1) is a potent and selective JNK inhibitor with IC50s of 290 nM and 500 nM for JNK3 and JNK2, respectively.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

JNK
Recptor

JNK
Research Area

——
Indication

——

Chemical Information

CAS Number

345986-38-1
Formula Weight

286.74
Molecular Formula

C13H7ClN4S
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : ≥ 31 mg/mL (108.11 mM )
SMILES

Clc1nccc(n1)C(C#N)c1nc2ccccc2s1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Serge Halazy, et al. Benzazole derivatives and their use as JNK modulators. EP1110957A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Norharmane

Norharmane is a natural β-carboline first isolated from plants of the Zygophyllaceae family.
AS601245

AS601245, an anti-Inflammatory JNK inhibitor, and Clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo-2 colon cancer cells .
Tanzisertib

Tanzisertib (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.Tanzisertib (CC-930) inhibits the formation of phospho-cJun in human PBMC stimulated by phorbol-12-myristate-13-acetate and phytohemeagglutinin (IC50=1 μM)[1] and it blocks the JNK pathway that is activated by pro-fibrotic cytokines in systemic sclerosis.

Sign In Join Free